Home › Research › Prevention trials
Beneficial Effects of Olive Oil and the Mediterranean Diet on Alzheimer’s Disease and Vascular Dementia: A Review
Aitor González-Cidad, Juan Carlos García-Moncó, Gustavo C. Román. Medicina, 2026-04-04
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
This diet has been shown to improve cognitive function in patients with mild cognitive impairment, Alzheimer’s disease, vascular cognitive impairment, and vascular dementia. The main mechanisms responsible for cognitive improvement include control of arterial hypertension by reducing systolic and diastolic blood pressure, lowering triglycerides and low-density lipoprotein cholesterol and increasing high-density lipoprotein cholesterol, along with improvement in fasting glucose, insulin levels, and hemoglobin A1c in subjects with type 2 diabetes mellitus, as well as lowering body mass index and obesity. The Mediterranean diet and olive oil induce—along with prevention of cardiovascular disease and stroke—a significant improvement of vascular risk factors, slowing the progression of both vascular dementia and Alzheimer’s disease. There is a need for additional placebo-controlled clinical trials to confirm the supportive nutritional role of extra-virgin olive oil in age-associated cognitive decline in the elderly.
What this study adds
Evidence grade: Low
This is a narrative review. This review reports that the Mediterranean diet and olive oil have been linked to improved cognitive function in people with mild cognitive impairment, Alzheimer's disease, and vascular dementia, mainly through effects on vascular risk factors. It calls for additional placebo-controlled trials, so it does not establish that olive oil or the diet treats or prevents these conditions.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
González-Cidad, A., García-Moncó, J. C., & Román, G. C. (2026). Beneficial Effects of Olive Oil and the Mediterranean Diet on Alzheimer’s Disease and Vascular Dementia: A Review. Medicina. https://doi.org/10.3390/medicina62040696
Vancouver
González-Cidad A, García-Moncó JC, Román GC. Beneficial Effects of Olive Oil and the Mediterranean Diet on Alzheimer’s Disease and Vascular Dementia: A Review. Medicina. 2026. doi:10.3390/medicina62040696. PMID: 42075568.
BibTeX
@article{gonzalezcidad2026-42075568,
author = {González-Cidad, Aitor and García-Moncó, Juan Carlos and Román, Gustavo C.},
title = {{Beneficial Effects of Olive Oil and the Mediterranean Diet on Alzheimer’s Disease and Vascular Dementia: A Review}},
journal = {Medicina},
year = {2026},
doi = {10.3390/medicina62040696},
pmid = {42075568},
url = {https://doi.org/10.3390/medicina62040696}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- This diet has been shown to improve cognitive function in patients with mild cognitive impairment, Alzheimer’s disease, vascular cognitive impairment, and vascular dementia.
- The main mechanisms responsible for cognitive improvement include control of arterial hypertension by reducing systolic and diastolic blood pressure, lowering triglycerides and low-density lipoprotein cholesterol and increasing high-density lipoprotein cholesterol, along with improvement in fasting glucose, insulin levels, and hemoglobin A1c in subjects with type 2 diabetes mellitus, as well as lowering body mass index and obesity.
- The Mediterranean diet and olive oil induce—along with prevention of cardiovascular disease and stroke—a significant improvement of vascular risk factors, slowing the progression of both vascular dementia and Alzheimer’s disease.
- There is a need for additional placebo-controlled clinical trials to confirm the supportive nutritional role of extra-virgin olive oil in age-associated cognitive decline in the elderly.
Why it matters
This review reports that the Mediterranean diet and olive oil have been linked to improved cognitive function in people with mild cognitive impairment, Alzheimer's disease, and vascular dementia, mainly through effects on vascular risk factors. It calls for additional placebo-controlled trials, so it does not establish that olive oil or the diet treats or prevents these conditions.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Study designnarrative review
- Evidence strengthLow
How this study scored 36/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Medicina) |
| Journal's citation record | 1 / 4 | Medicina: journal h-index 107 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | Design recorded as “narrative review”, which our rubric does not rank (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.5 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 3 / 6 | Cited 6.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Gustavo C. Román: h-index 68 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Houston Methodist: institution h-index 597 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42075568) |
| Free to read | 2 / 2 | Free to read |
| Total | 36 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 23.
Related studies in Prevention trials from nearby years
Also tagged “decline”
1,116 studies in the library carry the topic tag “decline”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,116 tagged studies.